Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Ethyl orthoformate | HCID 31214 | — |
| Reactant | Sodium Azide | HCID 33557 | — |
| Reactant | HCID 22380213 | HCID 22380213 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Product | HCID 22380290 | HCID 22380290 | — |
Reaction Steps
1-Ethyl-2-{[2-(2,5-difluorophenyl)-pyrazol-3-yl]methyl}-5-amino-1H-benzimidazole (104 mg) is treated with triethylorthoformate (4 eq) in acetic acid (10 mL) at reflux for 4 h. After concentrating the solution, acetic acid is re-added, sodium azide (4 eq) added, and the mixture heated at 70° C. for 3 h. After cooling, water (15 mL) is added and the mixture concentrated. The residue is taken up in ethyl acetate, washed with aqueous sodium bicarbonate (2×) then saturated aqueous sodium chloride, dried (MgSO4), concentrated, and purified by preparative silica gel chromatography to give 1-ethyl-2-{[2-(2,5-difluorophenyl)-pyrazol-3-yl]methyl}-5-(1,2,3,4-tetrazol-1-yl)-1H-benzimidazole, which is converted to the hydrochloride salt in ethyl acetate. LCMS MH+ 395.018
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07642267B2 |
|---|
| Source dataset | uspto-grants-2010_01 |
|---|
| ORD ID | ord-a3e20b18c21c41e48b7b3c1a6c142e4b |
|---|
| Source note | uspto-grants-2010_01 |
|---|